Updated February 2008
Principal Investigator
Goldyne Savad Institute of Gene Therapy
E-mail: rinat@hadassah.org.il
Phone: 972-2-677-7770
Fax: 972-2-643-0982
Affiliation
the Goldyne Savad Institute for Gene Therapy, and at the MRI/MRS lab., HBRC, Hadassah Hebrew University Hospital, Jerusalem
Education
1989-1992 B.Sc. in chemistry, Tel-Aviv University (with distinction).
1992-1993 One year of Master Degree in Chemistry, Weizmann Institute of Science.
1994-1998 Ph.D., Department of Biological Regulation, Weizmann Institute of Science.
Topic: Angiogenic processes: magnetic resonance microimaging studies.
Awards
2003-2004 Complexity Science Fellowship Award
2003-2004 Philip Morris Fellowship Award
1999 - Travel award to ISMRM, Philadelphia.
1998 - Best Poster Award, Workshop on MR in Experimental and Clinical Cancer Research, St. Louis, Missouri, USA.
1998 - Best Poster Award, 8th Annual Meeting of the European Tissue Repair Society. Copenhagen, Denmark.
1997 Travel Award to ISMRM, Vancouver.
1996-1998 Clore ScholarAward.
1996 Travel Award to ISMRM, New-York.
1991 Dean Excellency.
1990 Dean Excellency Award.
1989 Rector Excellency award.
Research interests
New noninvasive technique for quantitative assessment of tumor angiogenesis; development of MRI methods for evaluating VEGF-mediated pro-angiogenic therapy; assessment of anti-angiogenic therapy using MRI; analysis of the angiogenic potential of heparanase; angiogenic process in partial hepatectomy.
Selected recent publications
Matot I, Cohen K, Pappo O, Barash H, Abramovitch R. 2008. Liver response to hemorrhagic shock and subsequent resuscitation: MRI analysis. Shock 29(1):16-24.
Barash H, Gross E, Matot I, Edrei Y, Tsarfaty G, Spira G, Vlodavsky I, Galun E, Abramovitch R. 2007. Functional MR imaging during hypercapnia and hyperoxia: noninvasive tool for monitoring changes in liver perfusion and hemodynamics in a rat model. Radiology 243(3):727-35.
Ben Moshe T, Barash H, Kang TB, Kim JC, Kovalenko A, Gross E, Schuchmann M, Abramovitch R, Galun E, Wallach D. 2007. Role of caspase-8 in hepatocyte response to infection and injury in mice. Hepatology 45(4):1014-24.
Gafni Y, Zilberman Y, Ophir Z, Abramovitch R, Jaffe M, Gazit Z, Domb A, Gazit D, 2006. Design of a Filamentous Polymeric Scaffold for in vivo Guided Angiogenesis. Tissue Eng 11:3021-34.
Grunewald M, Avraham I, Dor Y, Bachar-Lustig E, Itin A, Yung S, Chimenti S, Landsman L, Abramovitch R, Keshet E. 2006. VEGF-induced adult neovascularization: recruitment, retention, and role of accessory cells. Cell 124(1):175-89.
Cohen I, Pappo O, Elkin M, San T, Bar-Shavit R, Hazan R, Peretz T, Vlodavsky I, Abramovitch R. 2006. Heparanase promotes growth, angiogenesis and survival of primary breast tumors. Int J Cancer 118(7):1609-17.
Zcharia E, Zilka R, Yaar A, Yacoby-Zeevi O, Zetser A, Metzger S, Sarid R, Naggi A, Casu B, Ilan N, Vlodavsky I, Abramovitch R. (2005) Heparanase accelerates wound angiogenesis and wound healing in mouse and rat models. FASEB J 19(2):211-21.
Darash-Yahana M, Pikarsky E, Abramovitch R, Karplus R, Kasem S, Pal B, Zeira E, Galun E and Peled A. (2004) Role of high expression levels of CXCR4 in tumor growth, vascularization and metastasis. FASEB J 18:1240-2.
Abramovitch R, Itzik A, Harel H, Nagler A, Vlodavsky I and Siegal T, (2004) Halofuginone inhibits angiogenesis and growth in implanted metastatic rat brain tumor model--an MRI study. Neoplasia 6:480-89.
Abramovitch R, Tavor E, Jacob-Hirsch J, Zeira E, Amariglio N, Pappo O, Rechavi G, Galun E, and Honigman A (2004). A pivotal role of cyclic AMP-responsive element binding protein in tumor progression. Cancer Res 64(4): 1338-1346.
Pikarsky E, Porat RM, Stein I, Abramovitch R, Amit S, Kasem S, Gutkovich-Pyest E, Urieli-Shoval S, Galun E, Ben-Neriah Y. (2004) NF-kappaB functions as a tumour promoter in inflammation-associated cancer. Nature 43:461-66.
Shabat S, Nyska A, Long PH, Goelman G, Abramovitch R, Ezov N, Levin-Harrus T, Peddada S, Redlich M, Yedgar S, Nyska M., (2004) Osteonecrosis in a Chemically Induced Rat Model of Human Hemolytic Disorders Associated with Thrombosis - A New Model for avascular Necrosis of Bone. Calcif Tissue Int 74(3):220-228.
Dor Y., Djonov V., Abramovitch R, Itin A, Fishman G.I., Carmeliet P, Goelman G, and Keshet E., (2002) Conditional organ-specific switching of VEGF expression: re-evaluating the feasibility of pro-angiogenic therapy. EMBO J 21(8):1939-1947.
Goldshmidt O, Zcharia E, Abramovitch R, Metzger S, Guatta-Rangini Z, Aingorn H, Friedmann Y, Mitrani E and Vlodavsky I. (2002) Cell surface expression and secretion of heparanase markedly promote tumor angiogenesis and metastasis. Proc Natl Acad Sci USA 99(15):10031-10036.
More in PubMed
Research group
Harel, Hila, Ph.D. student – Phone 677-7770/7918
Edrei, Yifat, M.Sc. student
Collaborators
Prof. Eithan Galun, Hadassah University Hospital
Dr. Idit Matot, Hadassah University Hospital
Dr. Eitan Gross, Hadassah University Hospital
Prof. Israel Vlodavsky, Hadassah University Hospital
Prof. Eli Keshet, Hebrew University
Prof. Tali Siegal, Hadassah University Hospital
Prof. Shmuel Ben-Sasson, Hebrew University
Prof. Alik Honigman, Hebrew University
RESEARCH SUMMARY
Analysis of vascular remodeling in vivo is a major challenge both for the study of the regulatory mechanisms of its initiation and inhibition, and for the clinical evaluation of pathological processes. In vivo assays for the study of angiogenesis are essential for the study of cancer, wound healing and reproduction. Angiogenesis is being assessed today by immunohistological staining of biopsy specimens, an invasive procedure that gives only local information.
Application of MRI as a noninvasive detection tool can provide a full 3-dimensional information about vessel density, functionality and maturation. Most of the previous approaches for the study of angiogenesis by MRI relied on the use of exogenous contrast agents. In our work, vascular development is followed by gradient echo (GE) MRI using the intrinsic contrast originating from deoxyhemoglobin (Blood Oxygenation Level Dependent (BOLD) contrast). Our research projects are the following:
• Applying a new noninvasive technique for quantitative assessment of tumor angiogenesis to the clinic
• Development of MRI methods for evaluating the feasibility of VEGF-mediated pro-angiogenic therapy
• Assessment of anti-angiogenic therapies in cancer models using MRI
• Analysis of the angiogenic potential of heparanase
Selected recent publications
Matot I, Cohen K, Pappo O, Barash H, Abramovitch R. 2008. Liver response to hemorrhagic shock and subsequent resuscitation: MRI analysis. Shock 29(1):16-24.
Barash H, Gross E, Matot I, Edrei Y, Tsarfaty G, Spira G, Vlodavsky I, Galun E, Abramovitch R. 2007. Functional MR imaging during hypercapnia and hyperoxia: noninvasive tool for monitoring changes in liver perfusion and hemodynamics in a rat model. Radiology 243(3):727-35.
Ben Moshe T, Barash H, Kang TB, Kim JC, Kovalenko A, Gross E, Schuchmann M, Abramovitch R, Galun E, Wallach D. 2007. Role of caspase-8 in hepatocyte response to infection and injury in mice. Hepatology 45(4):1014-24.
Gafni Y, Zilberman Y, Ophir Z, Abramovitch R, Jaffe M, Gazit Z, Domb A, Gazit D, 2006. Design of a Filamentous Polymeric Scaffold for in vivo Guided Angiogenesis. Tissue Eng 11:3021-34.
Grunewald M, Avraham I, Dor Y, Bachar-Lustig E, Itin A, Yung S, Chimenti S, Landsman L, Abramovitch R, Keshet E. 2006. VEGF-induced adult neovascularization: recruitment, retention, and role of accessory cells. Cell 124(1):175-89.
Cohen I, Pappo O, Elkin M, San T, Bar-Shavit R, Hazan R, Peretz T, Vlodavsky I, Abramovitch R. 2006. Heparanase promotes growth, angiogenesis and survival of primary breast tumors. Int J Cancer 118(7):1609-17.
Zcharia E, Zilka R, Yaar A, Yacoby-Zeevi O, Zetser A, Metzger S, Sarid R, Naggi A, Casu B, Ilan N, Vlodavsky I, Abramovitch R. (2005) Heparanase accelerates wound angiogenesis and wound healing in mouse and rat models. FASEB J 19(2):211-21.
Darash-Yahana M, Pikarsky E, Abramovitch R, Karplus R, Kasem S, Pal B, Zeira E, Galun E and Peled A. (2004) Role of high expression levels of CXCR4 in tumor growth, vascularization and metastasis. FASEB J 18:1240-2.
Abramovitch R, Itzik A, Harel H, Nagler A, Vlodavsky I and Siegal T, (2004) Halofuginone inhibits angiogenesis and growth in implanted metastatic rat brain tumor model--an MRI study. Neoplasia 6:480-89.
Abramovitch R, Tavor E, Jacob-Hirsch J, Zeira E, Amariglio N, Pappo O, Rechavi G, Galun E, and Honigman A (2004). A pivotal role of cyclic AMP-responsive element binding protein in tumor progression. Cancer Res 64(4): 1338-1346.
Pikarsky E, Porat RM, Stein I, Abramovitch R, Amit S, Kasem S, Gutkovich-Pyest E, Urieli-Shoval S, Galun E, Ben-Neriah Y. (2004) NF-kappaB functions as a tumour promoter in inflammation-associated cancer. Nature 43:461-66.
Shabat S, Nyska A, Long PH, Goelman G, Abramovitch R, Ezov N, Levin-Harrus T, Peddada S, Redlich M, Yedgar S, Nyska M., (2004) Osteonecrosis in a Chemically Induced Rat Model of Human Hemolytic Disorders Associated with Thrombosis - A New Model for avascular Necrosis of Bone. Calcif Tissue Int 74(3):220-228.
Dor Y., Djonov V., Abramovitch R, Itin A, Fishman G.I., Carmeliet P, Goelman G, and Keshet E., (2002) Conditional organ-specific switching of VEGF expression: re-evaluating the feasibility of pro-angiogenic therapy. EMBO J 21(8):1939-1947.
Goldshmidt O, Zcharia E, Abramovitch R, Metzger S, Guatta-Rangini Z, Aingorn H, Friedmann Y, Mitrani E and Vlodavsky I. (2002) Cell surface expression and secretion of heparanase markedly promote tumor angiogenesis and metastasis. Proc Natl Acad Sci USA 99(15):10031-10036.
Research group
Harel, Hila, Ph.D. student – Phone 677-7770/7918
Edrei, Yifat, M.Sc. student
Collaborators
Prof. Eithan Galun, Hadassah University Hospital
Dr. Idit Matot, Hadassah University Hospital
Dr. Eitan Gross, Hadassah University Hospital
Prof. Israel Vlodavsky, Hadassah University Hospital
Prof. Eli Keshet, Hebrew University
Prof. Tali Siegal, Hadassah University Hospital
Prof. Shmuel Ben-Sasson, Hebrew University
Prof. Alik Honigman, Hebrew University
RESEARCH SUMMARY
Analysis of vascular remodeling in vivo is a major challenge both for the study of the regulatory mechanisms of its initiation and inhibition, and for the clinical evaluation of pathological processes. In vivo assays for the study of angiogenesis are essential for the study of cancer, wound healing and reproduction. Angiogenesis is being assessed today by immunohistological staining of biopsy specimens, an invasive procedure that gives only local information.
Application of MRI as a noninvasive detection tool can provide a full 3-dimensional information about vessel density, functionality and maturation. Most of the previous approaches for the study of angiogenesis by MRI relied on the use of exogenous contrast agents. In our work, vascular development is followed by gradient echo (GE) MRI using the intrinsic contrast originating from deoxyhemoglobin (Blood Oxygenation Level Dependent (BOLD) contrast). Our research projects are the following:
• Applying a new noninvasive technique for quantitative assessment of tumor angiogenesis to the clinic
• Development of MRI methods for evaluating the feasibility of VEGF-mediated pro-angiogenic therapy
• Assessment of anti-angiogenic therapies in cancer models using MRI
• Analysis of the angiogenic potential of heparanase
|